Literature DB >> 1089039

Techniques for inhibiting tumor metastases.

H C Hoover, A S Ketcham.   

Abstract

Of the four major biological mechanisms of cancer spread, hematogenous dissemination is perhaps the most significant, as it usually heralds a fatal outcome for the patient. Recent experimental approaches have shown ways of altering the metastatic process and even totally inhibiting it in some animal models. It appears that these models may be applicable to certain human cancers. To prevent hematogenous metastasis formation the process must be inhibited at any one of four levels: 1) growth of the primary; 2) invasion of vessel walls; 3) release of viable tumor cells; or 4) entrapment and growth in distant organs. Judicious handling of the primary can decrease metastasis by minimizing the shedding of tumor cells. New experimental agents prevent the release of tumor cells from the primary by normalizing the blood vessels of the tumor. Warfarin, heparin, and fibrinolytic agents inhibit the entrapment of circulating tumor cells, presumably by their effect on coagulative mechanisms. A better understanding of the benefits of combined approaches to cancer using chemotherapy, irradiation, and immunotherapy, alone and as adjuncts to surgery, offers new opportunity to study methods of controlling metastatic disease.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1089039     DOI: 10.1002/1097-0142(197501)35:1<5::aid-cncr2820350103>3.0.co;2-1

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

1.  Letter: Prophylactic chemotherapy for breast cancer.

Authors:  J Marchant
Journal:  Br Med J       Date:  1976-06-26

2.  Remote metastases from intracranial tumours.

Authors:  A M Jackson; D I Graham
Journal:  J Clin Pathol       Date:  1978-08       Impact factor: 3.411

Review 3.  Recent advances in bone marrow scanning.

Authors:  S N Reske
Journal:  Eur J Nucl Med       Date:  1991

4.  The fibrinolytic system. A key to tumor metastasis?

Authors:  J M Malone; S L Wangensteen; W S Moore; K Keown
Journal:  Ann Surg       Date:  1979-09       Impact factor: 12.969

Review 5.  Shaping future strategies for the pharmacological control of tumor cell metastases.

Authors:  R G Greig; D L Trainer
Journal:  Cancer Metastasis Rev       Date:  1986       Impact factor: 9.264

Review 6.  Fibrin as a component of the tumor stroma: origins and biological significance.

Authors:  H F Dvorak; D R Senger; A M Dvorak
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

Review 7.  Cell detachment and metastasis.

Authors:  L Weiss; P M Ward
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

8.  The effect of chemotherapy on occult metastases after surgical removal of a non-immunogenic mouse carcinoma.

Authors:  T Zebro; E A Wright
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

9.  Highly metastatic 13762NF rat mammary adenocarcinoma cell clones stimulate bone marrow by secretion of granulocyte-macrophage colony-stimulating factor/interleukin-3 activity.

Authors:  C T McGary; M E Miele; D R Welch
Journal:  Am J Pathol       Date:  1995-12       Impact factor: 4.307

10.  Effects of Surgery and Chemotherapy on Metastatic Progression of Prostate Cancer: Evidence from the Natural History of the Disease Reconstructed through Mathematical Modeling.

Authors:  Leonid Hanin; Marco Zaider
Journal:  Cancers (Basel)       Date:  2011-09-20       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.